Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-08-073080
Filing Date
2008-11-25
Accepted
2008-11-25 17:27:43
Documents
1
Period of Report
2008-11-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4453
  Complete submission text file 0001104659-08-073080.txt   6952
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Reporting) CIK: 0001030617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49839 | Film No.: 081214761

Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 995-9800
IDENIX PHARMACEUTICALS INC (Issuer) CIK: 0001093649 (see all company filings)

EIN.: 450478605
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-49839 | Film No.: 081214762
SIC: 2834 Pharmaceutical Preparations